KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Gastroenterology / 2010 / Cilt: 21 - Sayı: 2

Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma

SELVİHAN BEYSEL
Zeynep Arzu YEĞİN
ABDULLAH MÜNCİ YAĞCI
Sayfa
197–198
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BEYSEL, S., YEĞİN, Z. A., YAĞCI, A. M. (2010). Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma. Turkish Journal of Gastroenterology, Cilt: 21 - Sayı: 2, 197–198. https://ajindex.com/articles/409797

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Tong Y, Qian J, Li Y, et al. The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients. Am J Hematol 2007; 82: 403-4
  2. Ifran A, Beyan C, Kaptan K. Development of zona zoster during bortezomib treatment in patients with relapsed/refractory multiple myeloma. Turk J Hematol 2008; 25: 1034
  3. Orciuolo E, Galimberti S, Petrini M. Bortezomib inhibits Tcell function versus infective antigenic stimuli in a dose-dependent manner in vitro. Leuk Res 2007; 31: 1026-7
  4. Wu KL, Van Wieringen W, Vellenga E, et al. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice. Haematologica 2005; 90: 996-7
  5. Rosinol L, Montoto S, Ciberia MT, Blade J. Bortezomib-induced severe hepatitis in multiple myeloma. Arch Intern Med 2005; 165: 464-5
  6. Menashe J. Managing and avoiding bortezomib toxicity. Commun Oncol 2007; 4: 480-4
  7. Vickrey E, Allen S, Mehta J, Singhal S. Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer 2009; 115: 229-32.